Number of the records: 1  

Minireview: Animal model of schizophrenia from the perspective of behavioral pharmacology: Effect of treatment on cognitive functions

  1. 1.
    0544568 - FGÚ 2022 RIV IE eng J - Journal Article
    Valeš, Karel - Holubová, K.
    Minireview: Animal model of schizophrenia from the perspective of behavioral pharmacology: Effect of treatment on cognitive functions.
    Neuroscience Letters. Roč. 761, Sep 14 (2021), č. článku 136098. ISSN 0304-3940. E-ISSN 1872-7972
    R&D Projects: GA MZd(CZ) EF16_025/0007444; GA ČR(CZ) GA18-09296S
    Institutional support: RVO:67985823
    Keywords : schizophrenia * antipsychotics * cognition * Morris water maze * pre-pulse inhibition * MK-801
    OECD category: Neurosciences (including psychophysiology
    Impact factor: 3.197, year: 2021
    Method of publishing: Limited access
    https://doi.org/10.1016/j.neulet.2021.136098

    Schizophrenia is a debilitating mental disorder characterized by positive, negative and cognitive symptoms. Whereas positive symptoms are satisfactorily addressed by current antipsychotic treatment, negative and cognitive symptomatic treatment remains largely ineffective. This review investigates the treatment efficacy regarding cognitive symptoms and evaluates the contribution of different monoamine receptor systems involved in schizophrenia pathophysiology to cognition. In the review, we included preclinical studies assessing the effect of different treatments on cognition in pre-pulse inhibition and two spatial cognitive tests. While pre-pulse inhibition investigates pre-attentive processes operating outside of conscious awareness, the spatial tasks require continuous attention and active engagement in task solving for a successful outcome. The schizophrenia-like phenotype was attained by acute or subchronic administration of non-competitive NMDA receptor antagonist MK-801.
    Permanent Link: http://hdl.handle.net/11104/0321416

     
     
Number of the records: 1